INVESTMENTS

Portfolio

WE’RE ALREADY DELIVERING
WITH OUR FIRST INVESTMENT (2019) IN COPENHAGEN BASED OCTARINE BIO

OUR FIRST INVESTMENT: OCTARINE BIO

  • Company Octarine
  • Investment Area Emerging Markets, Derived Products and Circular Economy
  • Location Copenhagen, Denmark
  • Website: https://octarinebio.com/
ABOUT

Octarine harnesses synthetic biology to develop functionally superior cannabinoid and psilocybin derivatives.
Our mission is to improve the health and well-being of people worldwide

Using our unique biosynthetic platform we engineer microorganisms to produce a range of natural and novel cannabinoid and psilocybin derived molecules with improved pharmacokinetic and therapeutic properties.

 

OUR SECOND INVESTMENT: HERBOLEA

ABOUT

Herbolea develops and licenses proprietary, solvent-less technologies to transform botanicals into superior quality products.

 

OUR THIRD INVESTMENT: PROHIBITION PARTNERS

ABOUT

Prohibition Partners is the B2B discovery platform for cannabis. They connect those in the industry and provide specialist information, data analytics and digital commerce solutions.

OUR FOURTH INVESTMENT: LEVA

ABOUT

Leva are improving the health and wellbeing of those living with chronic pain by building integrated solutions to manage chronic pain; combining clinical care, innovation and research.